Literature DB >> 11851356

Apoptosis and post-infarction left ventricular remodeling.

Alfonso Baldi1, Antonio Abbate, Rossana Bussani, Giuseppe Patti, Rosetta Melfi, Anna Angelini, Aldo Dobrina, Raffaele Rossiello, Furio Silvestri, Feliciano Baldi, Germano Di Sciascio.   

Abstract

Apoptosis is a common pathological feature in acute myocardial infarction (AMI), however, its role in the later phases (>10 days) of AMI and in post-infarction left ventricular remodeling has not been characterized. The aim of the study was to identify signs of ongoing cell apoptosis late post AMI. Sixteen hearts were collected at autopsy from subjects 12 to 62 days after the onset of AMI. In situ end-labeling of DNA fragmentation (TUNEL) and co-staining with caspase-3 were performed. Double-positive cells were defined as apoptotic and the apoptotic rate was calculated. Values are expressed as median and interquartile range. Co-stainings with muscle-actin, splicing factor (SC35), PCNA, bax and bcl-2 were also performed. Apoptotic rates at site of infarction [25.4% (17.0-28.4%)] were significantly higher v those at remote regions [0.7% (0.5-0.8%) P<0.001] and significantly correlated to left ventricular longitudinal and transverse diameters [ r = +0.70 (P=0.016) and r = +0.63 (P=0.004) respectively]. Moreover, in subjects with persistently occluded infarct-related artery (14 cases) there was a significantly higher apoptotic rate at the site of infarction compared to those (2 cases) with patent artery [26.0% (21.9-28.5%) v 4.5% (0.6% and 8,4%);P=0.033]. A significantly greater bax immuno-reactivity close to the infarction v remote areas was found (P<0.001). High grade apoptosis is present at sites of infarction in the later phases post AMI. This is more evident if the infarct-related artery is persistently occluded and signs of ventricular remodeling are present. These data may provide an explanation of progressive late left ventricular dysfunction. Copyright 2002 Academic Press.

Entities:  

Mesh:

Year:  2002        PMID: 11851356     DOI: 10.1006/jmcc.2001.1498

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  49 in total

1.  Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomerase.

Authors:  Stefano Toldo; Mariarosaria Boccellino; Barbara Rinaldi; Ignacio M Seropian; Eleonora Mezzaroma; Anna Severino; Lucio Quagliuolo; Benjamin W Van Tassell; Raffaele Marfella; Giuseppe Paolisso; Francesco Rossi; Ramesh Natarajan; Norbert Voelkel; Antonio Abbate; Filippo Crea; Alfonso Baldi
Journal:  Mol Med       Date:  2011-05-31       Impact factor: 6.354

2.  Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe?

Authors:  A Abbate; D Santini; G G L Biondi-Zoccai; S Scarpa; F Vasaturo; G Liuzzo; R Bussani; F Silvestri; F Baldi; F Crea; L M Biasucci; A Baldi
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

3.  Reduced post-infarction myocardial apoptosis in women: a clue to their different clinical course?

Authors:  G G L Biondi-Zoccai; A Abate; R Bussani; D Camilot; F D Giorgio; M-P D Marino; F Silvestri; F Baldi; L M Biasucci; A Baldi
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

4.  Apoptosis at a distance: remote activation of caspase-3 occurs early after myocardial infarction.

Authors:  Kerstin Schwarz; Gregor Simonis; Xinjian Yu; Stephan Wiedemann; Ruth H Strasser
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

5.  Cellular mechanisms in intermittent hypoxia-induced cardiac damage in vivo.

Authors:  Qian Han; Sze C Yeung; Mary S M Ip; Judith C W Mak
Journal:  J Physiol Biochem       Date:  2013-10-12       Impact factor: 4.158

6.  SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway.

Authors:  Antonio Cittadini; Maria Gaia Monti; Guido Iaccarino; Maria Carmina Castiello; Alfonso Baldi; Eduardo Bossone; Salvatore Longobardi; Alberto Maria Marra; Valentina Petrillo; Lavinia Saldamarco; Matthew John During; Luigi Saccà; Gianluigi Condorelli
Journal:  Cardiovasc Res       Date:  2012-08-08       Impact factor: 10.787

Review 7.  Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities.

Authors:  Jason J Gajarsa; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

8.  Carvedilol enhances mesenchymal stem cell therapy for myocardial infarction via inhibition of caspase-3 expression.

Authors:  Fatemat Hassan; Sarath Meduru; Kazuaki Taguchi; M Lakshmi Kuppusamy; Mahmoud Mostafa; Periannan Kuppusamy; Mahmood Khan
Journal:  J Pharmacol Exp Ther       Date:  2012-06-27       Impact factor: 4.030

9.  Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis.

Authors:  Nian Wan; Xiaoxiong Liu; Xiao-Jing Zhang; Yichao Zhao; Gangying Hu; Fengwei Wan; Rui Zhang; Xueyong Zhu; Hao Xia; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

Review 10.  Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation.

Authors:  Husnain Kh Haider; Muhammad Ashraf
Journal:  J Mol Cell Cardiol       Date:  2008-05-10       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.